Drug intelligence / Profile preview

serine

Development stage
Phase 2
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous
01

Overview

Serine is a non-essential amino acid that exists in two forms, L-serine and D-serine. L-serine is naturally present in the diet (found in foods like meat, dairy, soy products, sweet potatoes, eggs, and some seaweed) and is synthesized from glycine or threonine[1][3][6][8]. It plays critical roles in protein synthesis; biosynthesis of purines, pyrimidines, sphingolipids and phospholipids; neurotransmission; and as a precursor for other amino acids[6][8]. The hydroxyl side chain of serine contributes to protein polarity and serves as a site for phosphorylation to regulate protein function[6]. D-serine acts as an endogenous neuromodulator in the brain. It functions primarily as a co-agonist at NMDA-type glutamate receptors (N-methyl-D-aspartate receptors), modulating synaptic plasticity and neurotransmission. This mechanism has been investigated for potential therapeutic effects on schizophrenia (as adjunctive therapy), cognitive decline associated with neurological disorders such as Alzheimer's disease or ALS (amyotrophic lateral sclerosis), diabetic neuropathy, hyperhomocysteinemia, primary disorders of serine metabolism (such as 3-phosphoglycerate dehydrogenase deficiency), central nervous system injury, depression, insomnia and other neuropsychiatric conditions[1][5][6][7][8]. Serine supplementation is available both individually or within amino acid mixtures used clinically for parenteral nutrition. Some intravenous nutrition products containing serine are FDA-approved.

Other names
L-serineD-serinea-amino-b-hydroxy-propionic acid
02

Targets

GluN1 (Glutamate receptor ionotropic NMDA type subunit 1 (GluN1) glycine site)GRIN2A (NMDA receptor subunit 2A)GLRA1 (Glycine receptor subunit Alpha-1)

Beyond the preview

Go deeper on serine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on serine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call